Literature DB >> 11293439

Irritable bowel syndrome: is the search for lactose intolerance justified?

T J Parker1, J T Woolner, A T Prevost, Q Tuffnell, M Shorthouse, J O Hunter.   

Abstract

OBJECTIVES: To determine if confirmation of hypolactasia offers any benefit to the dietary treatment of patients with irritable bowel syndrome (IBS).
METHODS: One hundred and twenty-two consecutive IBS patients (37 male, 85 female) were given lactose hydrogen breath tests (LHBT). Those with positive LHBT followed a low lactose diet for 3 weeks. Those improving on the diet were given double-blind, placebo-controlled challenges (DBPCC) with 5 g, 10 g and 15 g of lactose and a placebo, to confirm lactose intolerance. Those who did not respond to the low lactose diet followed either an exclusion or low fibre diet. Symptoms scores were kept prior to the LHBT, 8 h post-LHBT and daily whilst following any dietary change. Patients with negative LHBT returned to clinic and subsequent dietary interventions were recorded.
RESULTS: LHBT was positive in 33/122 (27%) IBS patients. Syrr otom scores prior to LHBT were not significantly different between the two groups, but after LHBT the symptoms in the positive group were significantly worse. Twenty-three patients followed a low-lactose diet of which only nine (39%) improved. Six who did not improve followed an exclusion diet, three improved and all were intolerant of milk. Three tried a low fibre diet with two improving. DBPCC were inconclusive. In the negative LHBT group 35 agreed to try a diet and 24 improved (69%). Eight were intolerant of cow's milk.
CONCLUSIONS: Use of a low lactose diet was disappointing in IBS patients with lactose malabsorption. Food intolerance was demonstrated in IBS patients with positive or negative LHBT and milk was identified as a problem in both groups. DBPCC were inconclusive. There appears to be little advantage in trying to separate patients who malabsorb lactose from others with IBS.

Entities:  

Mesh:

Year:  2001        PMID: 11293439     DOI: 10.1097/00042737-200103000-00001

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  28 in total

1.  Chronic diarrhoea.

Authors:  R Spiller
Journal:  Gut       Date:  2007-12       Impact factor: 23.059

Review 2.  Food allergy in irritable bowel syndrome: The case of non-celiac wheat sensitivity.

Authors:  Pasquale Mansueto; Alberto D'Alcamo; Aurelio Seidita; Antonio Carroccio
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

3.  Rational investigations in irritable bowel syndrome.

Authors:  Christopher J Black; Alexander C Ford
Journal:  Frontline Gastroenterol       Date:  2019-06-06

Review 4.  Global burden of irritable bowel syndrome: trends, predictions and risk factors.

Authors:  Christopher J Black; Alexander C Ford
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-04-15       Impact factor: 46.802

5.  Treatment of Irritable Bowel Syndrome.

Authors:  Robin C. Spiller
Journal:  Curr Treat Options Gastroenterol       Date:  2003-08

6.  Food Intolerance: Dietary Treatments in Functional Bowel Disorders.

Authors:  Maria O'Sullivan; Colm O'Morain
Journal:  Curr Treat Options Gastroenterol       Date:  2003-08

Review 7.  New developments in the diagnosis and treatment of irritable bowel syndrome.

Authors:  George F Longstreth; Douglas A Drossman
Journal:  Curr Gastroenterol Rep       Date:  2002-10

Review 8.  Irritable bowel syndrome and food interaction.

Authors:  Rosario Cuomo; Paolo Andreozzi; Francesco Paolo Zito; Valentina Passananti; Giovanni De Carlo; Giovanni Sarnelli
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

Review 9.  Carbohydrate malabsorption in patients with non-specific abdominal complaints.

Authors:  Peter Born
Journal:  World J Gastroenterol       Date:  2007-11-21       Impact factor: 5.742

10.  Dietary Renaissance in IBS: Has Food Replaced Medications as a Primary Treatment Strategy?

Authors:  Marisa Spencer; William D Chey; Shanti Eswaran
Journal:  Curr Treat Options Gastroenterol       Date:  2014-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.